Related Experiment Video
Updated: Jun 24, 2026
07:27
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
Robotic laparoendoscopic single-site surgery using GelPort as the access platform
Robert J Stein1, Wesley M White, Raj K Goel
1Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
European Urology
|April 14, 2009
Summary
The GelPort system is a viable platform for robotic laparoendoscopic single-site surgery (R-LESS), enabling successful urologic procedures with minimal complications. This approach offers flexibility and adequate access, paving the way for future advancements in minimally invasive surgery.
Area of Science:
- Minimally Invasive Surgery
- Robotic Surgery
- Urologic Procedures
Background:
- Laparoendoscopic single-site surgery (LESS) offers minimal scarring for major urologic procedures.
- The da Vinci Surgical System enhances ergonomics but lacks an ideal platform for LESS.
- An ideal platform is needed to optimize robotic LESS (R-LESS) procedures.
Purpose of the Study:
- To evaluate the GelPort laparoscopic system as an access platform for R-LESS procedures.
- Assess the feasibility and outcomes of using GelPort in robotic minimally invasive urologic surgery.
Main Methods:
- 11 R-LESS procedures were performed at a single institution.
- The GelPort system was used as the access platform in the last four cases.
- Procedures included pyeloplasty, radical nephrectomy, and partial nephrectomy, with data collected on operative time, blood loss, and length of stay.
Main Results:
- All R-LESS procedures using GelPort were completed successfully without complications.
- Average operative time for pyeloplasty was 235 min with 38 cm³ EBL.
- Partial nephrectomy for an 11-cm angiomyolipoma had an OR time of 180 min and 600 cm³ EBL.
Conclusions:
- The GelPort system provides adequate port spacing and flexibility for R-LESS procedures.
- It offers acceptable surgical field access, particularly for specimen extraction.
- Further platform and instrumentation development is expected to enhance R-LESS procedures.